Liverpool biocampus mulls LABV

10 April 2012 The Royal Liverpool and Broadgreen University Hospitals Trust (RLBUHT) is considering using a local asset-backed vehicle (LABV) approach to build a new £28m life science and innovation centre.
On behalf of the University of Liverpool and Liverpool City Council, the Trust is seeking to market test private contractors to see how Liverpool's new Bio Innovation Centre - the the first phase of the delivery of an international life science bio-campus - could be financed and built. 

The authority is looking for feedback on whether to procure the building using Procure 21+, a restricted negotiated procedure or a local asset-backed vehicle company.

The deal will involve the construction of a new innovation centre "to connect academics, industry professionals, investors, clinicians and the NHS", according to a statement. The centre will be built on a 10 hectare site in the ownership of RLBUHT, with full planning permission for commercial and research development.

The institutions' key objective is for the new campus to place Liverpool alongside Boston and Singapore as a leading international centre for the life sciences. Procurement works are hoped to begin by the end of 2012 with the centre being in full operation by May 2014.

This page was last updated on:
7 October 2015.


The new politics

It might be easy to dismiss Labourís new leader as an irrelevance who will never win office, but his presence on the political stage will have important impacts

History Lessons

Mark Giblett, the former group head of project finance for Asia at SMBC, surveys the Asian PPP landscape and tells Paul Jarvis how governments are learning from past mistakes


Register now to get un-restricted access to all sections of the website.

Want to see more first? Try our free preview...